Cargando…
Systematic molecular profiling of acute leukemia cancer stem cells allows identification of druggable targets
Acute myeloid leukemia (AML) is one of the most prevalent and acute blood cancers with a poor prognosis and low overall survival rate, especially in the elderly. Although several new AML markers and drug targets have been recently identified, the rate of long-term cancer eradication has not improved...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586918/ https://www.ncbi.nlm.nih.gov/pubmed/36281397 http://dx.doi.org/10.1016/j.heliyon.2022.e11093 |